Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?

被引:0
|
作者
Abdallah, Nadine [1 ]
Kim, Seongho [2 ]
Ayash, Lois [2 ]
Klimecki, Scott [3 ]
Ventimiglia, Marie [3 ]
Alavi, Asif [2 ]
Ratanatharathorn, Voravit [2 ]
Uberti, Joseph [2 ]
Deol, Abhinav [2 ]
机构
[1] Wayne State Univ, Detroit Med Ctr, Dept Med, Detroit, MI USA
[2] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48202 USA
[3] Karmanos Canc Inst, Detroit, MI USA
关键词
ALGORITHM;
D O I
10.1038/s41409-019-0744-5
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:1655 / 1657
页数:3
相关论文
共 50 条
  • [21] Biosimilar G-CSF Based Mobilization of Peripheral Blood Hematopoietic Stem Cells for Autologous and Allogeneic Stem Cell Transplantation
    Schmitt, Michael
    Publicover, Amy
    Orchard, Kim H.
    Goerlach, Matthias
    Wang, Lei
    Schmitt, Anita
    Mani, Jiju
    Tsirigotis, Panagiotis
    Kuriakose, Reeba
    Nagler, Arnon
    THERANOSTICS, 2014, 4 (03): : 280 - 289
  • [22] Use of a biosimilar G-CSF in allogeneic stem cell mobilisation
    Azar, N.
    Choquet, S.
    Garnier, A.
    Weil, D. Roos
    Leblond, V.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S244 - S244
  • [23] Retrospective Analysis of Autologous Peripheral Blood Stem Cell Mobilization Using G-CSF Including Biosimilar
    Tsukada, Nobuhiro
    Ikeda, Masahiro
    Shingaki, Sumito
    Miyazaki, Kanji
    Meshitsuka, Sohsuke
    Yoshiki, Yumiko
    Abe, Yu
    Konoma, Yuko
    Iki, Seiko
    Suzuki, Kenshi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S136 - S137
  • [24] G-CSF BIOSIMILAR (ZARZIO®) STEM CELL MOBILIZATION IN SIBLING HEALTTHY DONORS
    Antelo, M.
    Zabalza, A.
    Anton, P.
    Zalba, S.
    Aznar, M.
    Vicente, E.
    Aoiz, I.
    Olavarria, E.
    HAEMATOLOGICA, 2013, 98 : 668 - 668
  • [25] Autologous haematopoietic stem cell mobilization in HIV positive patients: the role of plerixafor in association with G-CSF and chemotherapy
    Durante, C.
    Rupolo, M.
    Zanet, E.
    Lleshi, A.
    Agostini, F.
    Mazzucato, M.
    Michieli, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S326 - S326
  • [26] Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF
    Basak, G. W.
    Wiktor-Jedrzejczak, W.
    Apperley, J. F.
    Douglas, K. W.
    Gabriel, I. H.
    Geraldes, C.
    Huebel, K.
    Jaksic, O.
    Koristek, Z.
    Lanza, F.
    Lemoli, R.
    Mikala, G.
    Selleslag, D.
    Worel, N.
    Mohty, M.
    Duarte, R. F.
    BONE MARROW TRANSPLANTATION, 2012, 47 (07) : 1003 - 1005
  • [27] Cyclophosphamide or plerixafor and G-CSF for stem cell mobilization: initial cost comparison analysis
    Jagasia, M.
    Pickard, S.
    Chen, H.
    Dixon, S.
    Savani, B.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S24 - S24
  • [28] Superior Stem Cell Mobilization by a Combination of Plerixafor plus G-CSF in Patients with Thalassemia
    Yannaki, Evangelia
    Anagnostopoulos, Achilles
    Karponi, Garyfalia
    Zervou, Fani
    Constantinou, Varnavas
    Psatha, Nikoleta
    Bouinta, Asimina
    Jonlin, Erica
    Papayannopoulou, Thalia
    Stamatoyannopoulos, George
    MOLECULAR THERAPY, 2013, 21 : S11 - S11
  • [29] A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization
    Manko, Joanna
    Walter-Croneck, Adam
    Jawniak, Dariusz
    Grzasko, Norbert
    Gorska-Kosicka, Magdalena
    Cioch, Maria
    Dmoszynska, Anna
    PHARMACOLOGICAL REPORTS, 2014, 66 (02) : 239 - 242
  • [30] Investigation of stem cell mobilization using G-CSF and plerixafor in experimental autoimmune encephalomyelitis
    Oberhagemann, S. M.
    Ladigan, S.
    Marte, H.
    Heitmann, N.
    Nilius, V.
    Gold, R.
    Schroers, R.
    Faissner, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 221 - 222